Skip to main content
Stephen Gottschalk, MD, Pediatric Hematology & Oncology, Memphis, TN, St. Jude Children's Research Hospital

StephenGottschalkMD

Pediatric Hematology & Oncology Memphis, TN

Chair, Dept of BMT & Cellular Therapy, St Jude Children's Research Hospital

Dr. Gottschalk is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gottschalk's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1998 - 2001
  • Baylor College of Medicine (Houston)
    Baylor College of Medicine (Houston)Residency, Pediatrics, 1995 - 1998
  • University of Gottingen Faculty of Medicine
    University of Gottingen Faculty of MedicineClass of 1992

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2017 - 2025
  • TX State Medical License
    TX State Medical License 2001 - 2024
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • EBV/LMP-specific T Cells Maintain Remissions of T and B Cell EBV Lymphomas After Allogeneic Bone Marrow Transplantation  
    Stephen Gottschalk, Rayne Rouce, Catherine M Bollard, Malcolm K Brenner, Helen E Heslop, Blood

Abstracts/Posters

  • Lentiviral Gene Therapy with Low Dose Busulfan for Infants with X-SCID Results in the Development of a Functional Normal Immune System: Interim Results of an Ongoing P...
    Stephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Inducible MyD88 Signaling Enhances the Anti-AML Activity of BiTE-Secreting ENG T-Cells
    Stephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity
    Stephen Gottschalk, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • The Landscape of CART Beyond ALL. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Novel Leukaemia Therapy Aims to Treat Sick Kids Before Time Runs Out
    Novel Leukaemia Therapy Aims to Treat Sick Kids Before Time Runs OutNovember 14th, 2022
  • New Leukemia Therapy Aims to Treat Sick Children Before It's Too Late
    New Leukemia Therapy Aims to Treat Sick Children Before It's Too LateOctober 31st, 2022
  • Updates on Gene Therapy for ‘Bubble Boy’ Disease and Cellular Immunotherapy at ASGCT
    Updates on Gene Therapy for ‘Bubble Boy’ Disease and Cellular Immunotherapy at ASGCTMay 12th, 2022
  • Join now to see all

Hospital Affiliations